MAIA Biotechnology (MAIA) Stock: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.15
0.02 (1.77%)
▲
5d:
+4.55%
30d:
-8.0%
90d:
-10.16%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 06, 2026
10d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MAIA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MAIA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.56
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.14 to $1.33. The stock's valuation (Forward PE: 1.0) is in line with its historical norms (1.0). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.06, while resistance sits at $1.22.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+943.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.06, while resistance sits at $1.22.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+943.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.14 -
$1.33
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 943.5% below Wall St target ($12.00)
- NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.14 -
$1.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.06
Resistance Level
$1.22
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.04
Wall Street Target
$12.00
(+943.5%)
Valuation Premium vs History
+2.5% premium
PE vs Historical
1.0 vs 1.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$1.18
(+3%)
2-Year Target
$1.21
(+5%)
3-Year Target
$1.24
(+8%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.20
(+4%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 26, 2026 2:18 AM ET
Data refreshes hourly during market hours. Next update: 3:18 AM
Data refreshes hourly during market hours. Next update: 3:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 64 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$867 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 61 BUY |
